Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe record history now shows a new revision (v3.6.5) returned on 2026-07-31, bringing in newly surfaced sections such as Adverse Events, Baseline Characteristics, Participant Flow, Outcome Measures (Results), Study Design, and Study Status to the study record. This update broadens the displayed data and status details for the trial.SummaryDifference1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry, v3.6.4, has been added to the record history. This update replaces the previous revision, v3.6.3, signaling an update to the historical record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe history now shows 'Results Submitted' replacing 'No Results Posted'. This indicates that the trial results have been submitted and will appear in the record for review by researchers and participants.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous v3.6.2 entry was removed, indicating the latest version of the record history is now reflected.SummaryDifference0.1%

- Check44 days agoChange DetectedThe Record History adds a new revision entry for v3.6.2 and removes the previous v3.6.0 entry, updating the timeline of changes to the study record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now includes a note that recruitment is no longer open to participants, indicating a halt in enrollment. It also adds the new revision tag v3.6.0 and removes the previous tag v3.5.5 from the visible history.SummaryDifference0.4%

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.